CAR-T Treatment: Determining the Survival Gain in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Andrea Messori, Vera Damuzzo, Luca Leonardi, Laura Agnoletto, Marco Chiumente, Daniele Mengato
Topics & Concepts
Chimeric antigen receptorLymphomaMedicineOncologyRefractory (planetary science)Internal medicineMultiple myelomaDiffuse large B-cell lymphomaImmunotherapyCancerBiologyAstrobiologyCAR-T cell therapy research